Vincristine exhibits anti-cancer effects by enhancing cell apoptosis, while HMGB1 exhibits the opposite role by upregulating the anti-apoptotic myeloid leukemia 1 (MCL-1) protein levels, thus contributing to the autophagy-mediated protection of cancer cells [44]. Here, MCL1 is linked to cancer.